Best Current Prices — Our Top Two Recommended Vendors
These are the two vendors we get the most reader purchases from — both have strong third-party testing, real affiliate discount programs, and carry retatrutide in stock.
Current Research Peptide Pricing — All Vendors
Retatrutide is available as a research peptide from several US vendors. Price per milligram is the most useful comparison — vial sizes vary between vendors making direct price comparisons misleading without normalizing for amount.
| Vendor | Vial Size | Price | Price per mg | In Stock | Discount Available |
|---|---|---|---|---|---|
| Ascension Peptides Best Value | 20mg | $190 | $9.50/mg | ✓ Yes | 20% off first order |
| Peptide Partners #1 Tested | Various | Contact vendor | — | ✓ Yes | Code JGIANNA — 10% off |
| Biotech Peptides | 6mg | ~$100–150 | ~$17–25/mg | ✓ Yes | None confirmed |
| Limitless Life Nootropics | Various | VIP members | ~$10–15/mg | VIP only | Auto-tracked via link |
| Apollo Peptide Sciences | 10mg | ~$320 | ~$32/mg | ✓ Yes | Multi-pack bundles |
What Will Retatrutide Cost When FDA Approved?
Retatrutide is projected for FDA approval in 2027–2028. Based on how Eli Lilly priced tirzepatide and the broader GLP-1 market, here is the most realistic pricing forecast:
The Zepbound precedent: When tirzepatide launched as Zepbound for obesity, it had a list price of ~$1,059/month. Eli Lilly simultaneously launched a LillyDirect cash-pay program offering single-dose vials at $399–$549/month — roughly half the list price. Retatrutide will almost certainly follow a similar dual-pricing structure given Lilly's established pattern.
Analysts project retatrutide could generate $30 billion in annual sales by 2031, suggesting Lilly will price it at a meaningful premium to tirzepatide given its superior efficacy data.
Is the Research Peptide Price Worth It vs Waiting?
This is the question most readers are actually asking. The honest answer depends on your situation:
Research peptide route (now): At $9.50/mg from Ascension, a standard research protocol using 2mg/week starting dose costs roughly $19/week or $76/month — rising to approximately $190/month at the 12mg maintenance dose. That's significantly less than the projected commercial price and available today. The tradeoff is less regulatory oversight and the requirement to source and reconstitute yourself.
Wait for commercial approval (2027–2028): Full physician oversight, pharmaceutical-grade manufacturing, potential insurance coverage. The right choice for anyone with complex health conditions, medications, or who wants supervised care.
Clinical trial (free): If you qualify for an active TRIUMPH trial, you receive the drug free under full physician supervision. Check clinicaltrials.gov for open TRIUMPH sites near you.
How to Get the Best Price Right Now
If you're accessing retatrutide as a research peptide, three things maximize your value:
1. Buy the largest vial size. Price per mg drops significantly with larger vials. Ascension's 20mg vial at $9.50/mg is considerably cheaper per mg than smaller options from other vendors.
2. Use affiliate discounts. Our links give you 20% off your first Ascension order and 10% off Peptide Partners with code JGIANNA — those are real savings on already competitive prices.
3. Verify COAs before purchasing. A slightly cheaper vial from an unverified vendor may contain significantly less active compound than labeled. The per-mg savings disappear if you're only getting 60% of the stated dose.
For the full vendor comparison including BPC-157 pricing and shipping details, see our complete peptide vendor guide.